MenaQ7 MK-7
MenaQ7 MK-7 est un supplément de vitamine K2, spécifiquement la variante MK-7, qui joue un rôle crucial dans la coagulation du sang et la santé des os. Il s'agit d'une forme de ménaquinone, un type de vitamine K.
Aperçu de l'Efficacité et des Risques
Condition | Efficacité | Détails |
|---|---|---|
| Ostéoporose | MenaQ7 MK-7's role in bone health is well-documented. It helps in the carboxylation of osteocalcin, which is essential for bone mineralization. This action is associated with improved bone density and reduced risk of osteoporotic fractures. | |
| Santé cardiovasculaire | By reducing arterial calcification and improving blood vessel elasticity, MenaQ7 MK-7 contributes to overall cardiovascular health. Its effects on MGP activation are crucial for preventing the calcification of arteries, thereby reducing cardiovascular risk. | |
| Santé des os | MenaQ7 MK-7 is involved in the activation of osteocalcin, a protein necessary for bone mineralization. Studies have demonstrated its role in improving bone mineral density and reducing the risk of fractures, particularly in postmenopausal women. | |
| Calcification vasculaire | MenaQ7 MK-7 has been shown to reduce vascular calcification by activating MGP. This is critical for maintaining vascular health and preventing cardiovascular diseases associated with calcification. | |
| Calcification artérielle/Athérosclérose | MenaQ7 MK-7 has been shown to inhibit arterial calcification and reduce the risk of cardiovascular disease by activating matrix Gla protein (MGP), a potent inhibitor of arterial calcification. Clinical trials and meta-analyses support its efficacy in reducing arterial stiffness and calcification. | |
| Interaction potentielle avec les anticoagulants. | MenaQ7 MK-7 peut interagir avec les médicaments anticoagulants comme la warfarine, modifiant potentiellement leur efficacité ou augmentant le risque de saignement. |
Complément Recommandé
Aucune combinaison spécifique trouvée pour MenaQ7 MK-7 pour le moment.